Suppr超能文献

使用基于脂质的递送系统增强肠道药物溶解

Enhancing intestinal drug solubilisation using lipid-based delivery systems.

作者信息

Porter Christopher J H, Pouton Colin W, Cuine Jean F, Charman William N

机构信息

Department of Pharmaceutics, Victorian College of Pharmacy, Monash University (Parkville campus), Parkville, Victoria 3052, Australia.

出版信息

Adv Drug Deliv Rev. 2008 Mar 17;60(6):673-91. doi: 10.1016/j.addr.2007.10.014. Epub 2007 Nov 7.

Abstract

Lipid-based delivery systems are finding increasing application in the oral delivery of poorly water-soluble, lipophilic drugs. Whilst lipidic dose forms may improve oral bioavailability via several mechanisms, enhancement of gastrointestinal solubilisation remains argueably the most important method of absorption enhancement. This review firstly describes the mechanistic rationale which underpins the use of lipid-based delivery systems to enhance drug solubilisation and briefly reviews the available literature describing increases in oral bioavailability after the administration of lipid solution, suspension and self-emulsifying formulations. The use of in vitro methods including dispersion tests and more complex models of in vitro lipolysis as indicators of potential in vivo performance are subsequently described, with particular focus on recent data which suggests that the digestion of surfactants present in lipid-based formulations may impact on formulation performance. Finally, a series of seven guiding principles for formulation design of lipid-based delivery systems are suggested based on an analysis of recent data generated in our laboratories and elsewhere.

摘要

基于脂质的给药系统在口服难溶性亲脂性药物的递送中应用越来越广泛。虽然脂质剂型可通过多种机制提高口服生物利用度,但增强胃肠道溶解作用仍然可以说是最重要的吸收增强方法。本综述首先描述了使用基于脂质的给药系统增强药物溶解作用的作用机制原理,并简要回顾了描述脂质溶液、混悬液和自乳化制剂给药后口服生物利用度增加的现有文献。随后描述了使用体外方法,包括分散试验和更复杂的体外脂解模型作为体内潜在性能指标,特别关注最近的数据,这些数据表明基于脂质的制剂中存在的表面活性剂的消化可能会影响制剂性能。最后,基于对我们实验室和其他地方产生的最新数据的分析,提出了一系列七条基于脂质的给药系统制剂设计指导原则。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验